featured
Outcomes of Extending Dupilumab Dosing Intervals in Patients With Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Extending dupilumab dosing intervals in atopic dermatitis: A prospective observational study in a South European tertiary hospital
J Eur Acad Dermatol Venereol 2023 Sep 20;[EPub Ahead of Print], C Valente, P Farinha, B DuarteFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.